- Home - News
- TWI News | TV
- Polls
- Cartoons
- Year In Review
- News Archive
- Crime & Punishment
- Politics
- Regional
- Editorial
- Health
- Ghanaians Abroad
- Tabloid
- Africa
- Religion
- Election 2020
- Coronavirus
- News Videos | TV
- Photo Archives
- News Headlines
- Press Release
- News Blogs
Revna Biosciences receives historic FDA approval for NeuMoDx™ 96 from QIAGEN, the first in Sub-Saharan Africa
 |
Co-Founder and CEO of Revna Biosciences, Dr Derrick Akpalu |
